First participant enrolled in EquilibriX S study
Category: News
Agency clarifies UK pathway for emerging therapies
Priority review granted for first‑in‑class Tourette therapy
First guidance for a licensed hyperhidrosis treatment
Company receives USD 10 million upfront
Partnership expands access to men’s health treatment
Saffron trial delivers positive results
Phase 3 study shows strong efficacy
Rigel makes Veppanu available across US
